BHLHE40-AS1 Gene

Name BHLHE40 antisense RNA 1
Description Predicted to be involved in SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition. Predicted to be part of signal recognition particle, endoplasmic reticulum targeting. [provided by Alliance of Genome Resources, Mar 2025]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n BHLHE40‑AS1 is a long noncoding RNA that appears to play a pivotal role in cancer progression. In breast cancer, particularly in ductal carcinoma in situ (DCIS), increasing expression of BHLHE40‑AS1 is associated with enhanced cell proliferation, motility, and invasion, thereby facilitating the transition to invasive ductal carcinoma. Mechanistically, BHLHE40‑AS1 modulates interleukin‑6/signal transducer and activator of transcription 3 (STAT3) signaling through interactions with factors such as interleukin enhancer‑binding factor 3, which promotes a proinflammatory and immune‑permissive microenvironment."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Furthermore, in papillary thyroid carcinoma, BHLHE40‑AS1 has been incorporated into an m6A‑related long noncoding RNA prognostic model, where its expression correlates with immune checkpoint expression (e.g., PD‑L1), tumor microenvironment characteristics, and various clinicopathological features, thereby serving as a useful prognostic indicator."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " \n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Broader analyses of lncRNA‑associated protein–protein interaction modules and germline genetic markers in different cancers underscore the importance of antisense lncRNAs, including BHLHE40‑AS1, in modulating complex gene expression networks and influencing diverse molecular mechanisms underlying cancer progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Rebecca S DeVaux, Ali S Ropri, Sandra L Grimm, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA BHLHE40-AS1 promotes early breast cancer progression through modulating IL-6/STAT3 signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.29621"}], "href": "https://doi.org/10.1002/jcb.29621"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31907974"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31907974"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yinde Huang, Xin Li, Wenbin Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of the prognostic significance and potential mechanisms of lncRNAs associated with m6A methylation in papillary thyroid carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int Immunopharmacol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.intimp.2021.108286"}], "href": "https://doi.org/10.1016/j.intimp.2021.108286"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34735975"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34735975"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Chih-Hsun Wu, Chia-Lang Hsu, Pei-Chun Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of lncRNA functions in lung cancer based on associated protein-protein interaction modules."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep35939"}], "href": "https://doi.org/10.1038/srep35939"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27786280"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27786280"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Hongji Dai, Xinlei Chu, Qian Liang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide association and functional interrogation identified a variant at 3p26.1 modulating ovarian cancer survival among Chinese women."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Discov (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41421-021-00342-6"}], "href": "https://doi.org/10.1038/s41421-021-00342-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34930913"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34930913"}]}]}]}
NCBI Gene ID 100507582
API
Download Associations
Predicted Functions View BHLHE40-AS1's ARCHS4 Predicted Functions.
Co-expressed Genes View BHLHE40-AS1's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View BHLHE40-AS1's ARCHS4 Predicted Functions.

Functional Associations

BHLHE40-AS1 has 730 functional associations with biological entities spanning 2 categories (cell line, cell type or tissue, gene, protein or microRNA) extracted from 9 datasets.

Click the + buttons to view associations for BHLHE40-AS1 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of BHLHE40-AS1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of BHLHE40-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CellMarker Gene-Cell Type Associations cell types associated with BHLHE40-AS1 gene from the CellMarker Gene-Cell Type Associations dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of BHLHE40-AS1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of BHLHE40-AS1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of BHLHE40-AS1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of BHLHE40-AS1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of BHLHE40-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of BHLHE40-AS1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.